Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 8/20 | 0.54 |
| ▸ | RAB9A | P51151 | 7/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.54 |
| ▸ | NPC1 | O15118 | 6/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | KMO | O15229 | 1/20 | 0.53 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.52 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.52 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.52 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.52 |
| ▸ | PRKDC | P78527 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10471594 | 0.93 | ALDH1A1 (0.61) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL610420 | 0.89 | ALDH1A1 (0.56) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL608471 | 0.87 | KMO (0.68) | LMNAALDH1A1HPGDHSD17B10KDM4E | |
| SCHEMBL611868 | 0.85 | MAPT (0.68) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL610702 | 0.84 | NPC1 (0.66) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL614472 | 0.84 | NPC1 (0.66) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL8246379 | 0.83 | ALDH1A1 (0.59) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL14982132 | 0.82 | ALDH1A1 (0.61) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL50238 | 0.82 | SMN1; SMN2 (0.74) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL610092 | 0.82 | ALDH1A1 (0.64) | LMNAALDH1A1HPGDALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3950724-B1 | CONJUGATED DIENE COPOLYMER AND METHOD FOR MANUFACTURING CONJUGATED DIENE COPOLYMER | ZEON CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12139572-B2 | Conjugated diene copolymer and method for manufacturing conjugated diene copolymer | ZS ELASTOMERS CO., LTD. (JP) | 2024-11-12 | — | — | US | disclosed |
| EP-3604365-B1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | SUMITOMO CHEMICAL CO (JP) | 2024-04-24 | — | — | EP | disclosed |
| CN-110461893-B | Conjugated diene polymer and method for producing conjugated diene polymer | 住友化学株式会社 | 2023-10-27 | — | — | CN | disclosed |
| US-11377513-B2 | Conjugated diene polymer and method for producing conjugated diene polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-07-05 | — | — | US | disclosed |
| US-20220185919-A1 | CONJUGATED DIENE COPOLYMER AND METHOD FOR MANUFACTURING CONJUGATED DIENE COPOLYMER | ZS ELASTOMERS CO., LTD. (JP) | 2022-06-16 | — | — | US | disclosed |
| EP-3950724-A1 | CONJUGATED DIENE COPOLYMER AND METHOD FOR MANUFACTURING CONJUGATED DIENE COPOLYMER | ZS Elastomers Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| WO-2020196886-A1 | CONJUGATED DIENE COPOLYMER AND METHOD FOR MANUFACTURING CONJUGATED DIENE COPOLYMER | ＺＳエラストマー株式会社 | 2020-10-01 | — | — | WO | disclosed |
| EP-3239183-B1 | MODIFIED CONJUGATED DIENE POLYMER, AND POLYMER COMPOSITION CONTAINING SAID POLYMER | SUMITOMO CHEMICAL CO (JP) | 2020-03-11 | — | — | EP | disclosed |
| EP-3604365-A1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | Sumitomo Chemical Company Limited (JP) | 2020-02-05 | — | — | EP | disclosed |
| EP-1334985-B1 | Process for producing modified polymer rubber | SUMITOMO CHEMICAL CO (JP) | 2008-08-20 | — | — | EP | disclosed |
| US-20080090782-A1 | Materials and methods to potentiate cancer treatment | LUITPOLD PHARMACEUTICALS, INC. (US) | 2008-04-17 | — | — | US | disclosed |
| US-7179912-B2 | Materials and methods to potentiate cancer treatment | ICOS CORPORATION (US) | 2007-02-20 | — | — | US | disclosed |
| US-6818710-B2 | Process for producing modified polymer rubber | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-11-16 | — | — | US | disclosed |
| US-6765065-B2 | ENDCAPPING BUTADIENE-STYRENE COPOLYMER IN SOLVENT, EMULSION POLYMERIZATION; MOTORCAR TIRES, IMPACT RESILIENCE, FUEL SAVING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-07-20 | — | — | US | disclosed |
| US-20030216522-A1 | Process for producing modified polymer rubber | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-11-20 | — | — | US | disclosed |
| EP-1351946-A2 | MATERIALS AND METHODS TO POTENTIATE CANCER TREATMENT | ICOS CORPORATION (US) | 2003-10-15 | — | — | EP | disclosed |
| US-20030153692-A1 | Process for producing modified polymer rubber | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-08-14 | — | — | US | disclosed |
| EP-1334985-A1 | Process for producing modified polymer rubber | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-08-13 | — | — | EP | disclosed |
| WO-2002020500-A2 | MATERIALS AND METHODS TO POTENTIATE CANCER TREATMENT | ICOS CORPORATION (US) | 2002-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090782-A1 | Materials and methods to potentiate cancer treatment | DCK, CHEK2, CHEK1 | LMNA 834/4885ALDH1A1 3519/4885HPGD 1218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.